Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type

European Journal of Immunology

Volumn 34, Issue 1, 2004, Pages 56-65

  Stenström, Martin ^a   Sköld, Markus ^a,d   Ericsson, Anna ^a   Beaudoin, Lucie ^b   Sidobre, Stephane ^c   Kronenberg, Mitchell ^c   Lehuen, Agnès ^b   Cardell, Susanna ^a  

^a LUND UNIVERSITY   (Sweden)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD1d; Cytokines; NKT cells; Subsets; TCR

Indexed keywords

ALPHA2 INTEGRIN; ANTIGEN; CD1D ANTIGEN; CD69 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; NK1.1 ANTIGEN; PROTEIN; RECEPTOR SUBTYPE; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW; CANONICAL ANALYSIS; CLASSIFICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE CONTROL; GENE AMPLIFICATION; IMMUNE RESPONSE; IMMUNOLOGY; INFECTION; INTERFERON PRODUCTION; INTERPHASE; LYMPHOCYTE FUNCTION; METABOLISM; METASTASIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; BONE MARROW; CYTOKINES; INTEGRIN ALPHA2; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MICE; ORGAN SPECIFICITY; PROTEINS; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 1642432122     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323963     Document Type: Article

References (44)

1. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562.
2. Porcelli, S. A. and Modlin, R. L., The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999. 17: 297-329.
3. + T lymphocytes. Science 1995. 268: 863-865.
4. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 1995. 182: 993-1004.
5. Park, S. H., Roark, J. H. and Bendelac, A., Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 1998. 160: 3128-3134.
6. Behar, S. M., Podrebarac, T. A., Roy, C. J., Wang, C. R. and Brenner, M. B., Diverse TCRs recognize murine CD1. J. Immunol. 1999. 162: 161-167.
7. Zeng, D., Dick, M., Cheng, L., Amano, M., Dejbakhsh-Jones, S., Huie, P., Sibley, R. and Strober, S., Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J. Exp. Med. 1998. 187: 525-536.
8. Baron, J. L., Gardiner, L., Nishimura, S., Shinkai, K., Locksley, R. and Ganem, D., Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002. 16: 583-594.
9. + T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 1997. 159: 2240-2249.
10. Yoshimoto, T. and Paul, W. E., CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 1994. 179: 1285-1295.
11. Sumida, T., Sakamoto, A., Murata, H., Makino, Y., Takahashi, H., Yoshida, S., Nishioka, K., Iwamoto, I. and Taniguchi, M., Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J. Exp. Med. 1995. 182: 1163-1168.
12. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 1996. 156: 4035-4040.
13. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 1996. 26: 2989-2998.
14. Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk S. P., Strominger, J. L. and Hafler, D. A., Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998. 391: 177-181.
15. Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J. F. and Monteiro, R. C., Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 1998. 188: 1831-1839.
16. Mars, L. T., Laloux, V., Goude, K., Desbois, S., Saoudi, A., Van Kaer, L., Lassmann, H., Herbelin, A., Lehuen, A. and Liblau, R. S., Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 2002. 168: 6007-6011.
17. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M. and Taniguchi, M., Requirement for Valpha-14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.
18. Smyth, M. J., Crowe, N. Y., Hayakawa, Y., Takeda, K., Yagita, H. and Godfrey, D. I., NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 2002. 14: 165-171.
19. + T cells induces monocyte chemoattractant protein-1 in early listeriosis. J. Immunol. 1997. 159: 7-10.
20. + effector function against intracellular infection. J. Exp. Med. 1996. 184: 131-139.
21. Nieuwenhuis, E. E., Matsumoto, T., Exley, M., Schleipman, R. A., Glickman, J., Bailey, D. T., Corazza, N., Colgan, S. P., Onderdonk, A. B. and Blumberg, R. S., CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 2002. 8: 588-593.
22. Hansen, D. S., Siomos, M. A., De Koning-Ward, T., Buckingham, L., Crabb, B. S. and Schofield, L., CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses. Eur. J. Immunol. 2003. 33: 2588-2598.
23. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986. 136: 2348-2357.
24. Arase, H., Saito, T., Phillips, J. H. and Lanier, L. L., Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J. Immunol. 2001. 167: 1141-1144.
25. Skold, M., Rytter, A., Ivars, F. and Cardell, S., Characterization of subpopulations of T cell receptor intermediate (TCRint) T cells. Scand. J. Immunol. 1999. 49: 611-619.
26. Behar, S. M. and Cardell, S., Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions. Semin. Immunol. 2000.12: 551-560.
27. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M., CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
28. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754.
29. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. and Bendelac, A., In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 2000. 191: 1895-1903.
30. + T cells with a transgenic variant TCR. J. Immunol. 2000. 165: 168-174.
31. Hammond, K. J., Pelikan, S. B., Crowe, N. Y., Randle-Barrett, E., Nakayama, T., Taniguchi, M., Smyth, M. J., van Driel, I. R., Scollay, R., Baxter, A. G. and Godfrey, D. I., NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 1999. 29: 3768-3781.
32. +) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 2002. 99: 1259-1266.
33. Sköld, M., Stenström, M., Sidobre, S., Höglund, P., Kronenberg, M. and Cardell, S., MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T cell receptor type. Immunology 2003, in press.
34. Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J. and MacDonald, H. R., Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 1999. 162: 6410-6419.
35. Exley, M. A., Tahir, S. M., Cheng, O., Shaulov, A., Joyce, R., Avigan, D., Sackstein, R. and Balk, S. P., A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J. Immunol. 2001. 167: 5531-5534.
36. Exley, M. A., He, Q., Cheng, O., Wang, R. J., Cheney, C. P., Balk, S. P. and Koziel, M. J., Cutting edge: compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 2002. 168: 1519-1523.
37. Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B., Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002. 195: 625-636.
38. Lee, P. T., Benlagha, K., Teyton, L. and Bendelac, A., Distinct functional lineages of human V(alpha)24 natural killer T cells. J. Exp. Med. 2002. 195: 637-641.
39. Smyth, M. J. and Godfrey, D. I., NKT cells and tumor immunity - a double-edged sword. Nat. Immunol. 2000. 1: 459-460.
40. Beaudoin, L., Laloux, V., Novak, J., Lucas, B. and Lehuen, A., NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002. 17: 725-736.
41. + T cells in autoimmune diabetes. Nat. Immunol. 2001. 2: 1117-1125.
42. + T cells. J. Immunol. 2001. 166: 4209-4215.
43. + T cells. Eur. J. Immunol. 2000. 30: 2488-2496.
44. Openshaw, P., Murphy, E. E., Hosken, N. A., Maino, V., Davis, K., Murphy, K. and O'Garra, A., Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 1995. 182: 1357-1367.